BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1345@pharmaconomics
DTSTAMP:20260707T034704Z
DTSTART;VALUE=DATE:20260617
DTEND;VALUE=DATE:20260618
SUMMARY:GSK Approval — Utebzi
DESCRIPTION:A final FDA approval decision on Utebzi for complicated urinary tract infections (cUTIs) is expected Jun 17\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1131399/000165495426006036/a7252i.htm\n\nTrack it: https://www.pharmaconomics.com/e/1345
URL:https://www.pharmaconomics.com/e/1345
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:GSK catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR